Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients

Journal of Virology

Volumn 77, Issue 3, 2003, Pages 1940-1950

  Babik, Jennifer M ^a,b   Holodniy, Mark ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AIDS Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENTROPY; GENE SEQUENCE; GENETIC DISTANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIVERSITY; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; VIRAL ENVELOPE PROTEINS;

EID: 0037301349     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.3.1940-1950.2003     Document Type: Article

References (56)

1. Berger, A., M. von Depka Prondzinski, H. W. Doerr, H. Rabenau, and B. Weber. 1996. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J. Med. Virol. 48:339-343.
2. Booth, J. C., U. Kumar, D. Webster, J. Montajardino, and H. C. Thomas. 1998. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27:223-227.
3. Bruno, R., P. Sacchi, and G. Filice. 2001. Hepatitis C virus dynamics during antiretroviral therapy. Blood 97:3318.
4. Daar, E. S., H. Lynn, S. Donfield, E. Gomperts, M. W. Hilgartner, W. K. Hoots, D. Chernoff, S. Arkin, W.-Y. Wong, C. A. Winkler, and the Hemophilia Growth and Development Study. 2001. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J. Acquir. Immune Defic. Syndr. 26:466-472.
5. Daar, E. S., H. Lynn, S. Donfield, E. Gomperts, S. J. O'Brien, M. W. Hilgartner, W. K. Hoots, D. Chernoff, S. Arkin, W.-Y. Wong, C. A. Winkler, and the Hemophilia Growth and Development Study. 2001. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J. Infect. Dis. 183:589-595.
6. Devereux, H. L., D. Brown, G. M. Dusheiko, V. C. Emery, and C. A. Lee. 1997. Long-term evolution of the 5′UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients. J. Gen. Virol. 78:583-590.
7. Dieterich, D. T. 1999. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am. J. Med. 107:79S-84S.
8. Dodig, M., and A. S. Tavill. 2001. Hepatitis C and human immunodeficiency virus coinfections. J. Clin. Gastroenterol. 33:367-374.
9. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Merpolder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
10. Garcia-Samaniego, J., V. Soriano, J. Castilla, R. Bravo, A. Moreno, J. Carbo, A. Iniguez, J. Gonzalez, F. Munoz, et al. 1997. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am. J. Gastroenterol. 92:1130-1134.
11. Gavazzi, G., G. Richallet, P. Morand, O. Bouchard, A. Bosseray, P. Leclercq, and M. Micoud. 1998. Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV. Pathol. Biol. 46:412-415.
12. Goedert, J. J., A. Hatzakis, K. E. Sherman, and M. E. Eyster. 2001. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J. Infect. Dis. 184:1202-1205.
13. Gonzalez-Peralta, R. P., K. Qian, J. Y. She, G. L. Davis, T. Ohno, M. Mizokami, and J. Y. Lau. 1996. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J. Med. Virol. 49:242-247.
14. Greub, G., B. Ledergerber, M. Battegay, P. Grob, L. Perrin, H. Furrer, P. Burgisser, P. Erb, K. Boggian, J. C. Piffaretti, B. Hirschel, P. Janin, P. Francioli, M. Flepp, and A. Telenti. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800-1805.
15. He, L., H. Terunuma, H. Hanabusa, A. Iwamoto, S. Oka, F. Tanabe, N. Chiba, M. Kurimoto, M. Ikeda, H. Okamura, J. Dai, Y. Iwatani, T. Ishida, and M. Ito. 2000. Interleukin 18 and interleukin 1β production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacs. AIDS Res. Hum. Retrovir. 16:345-353.
16. Honda, M., S. Kaneko, A. Sakai, M. Unoura, S. Murakami, and K. Kobayashi. 1994. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20:1144-1151.
17. Imami, N., C. Antonopoulos, G. A. Hardy, B. Gazzard, and F. M. Gotch. 1999. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res. Hum. Retrovir. 15:1499-1508.
18. Kao, J. H., P. J. Chen, M. Y. Lai, T. H. Wang, and D. S. Chen. 1995. Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. J. Infect. Dis. 172:261-264.
19. Kato, N., Y. Ootusuyama, T. Tanaka, M. Nakazawa, M. Hijikata, and K. Shimotohno. 1994. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:4776-4784.
20. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, R. H. Purcell, et al. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
21. Koizumi, K., N. Enomoto, N. Kurosaki, T. Murakami, N. Izumi, F. Marumo, and C. Sato. 1995. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30-35.
22. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
23. Kumar, U., J. Monjardino, and H. C. Thomas. 1994. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106:1072-1075.
24. Kurosaki, M., N. Enomoto, F. Marumo, and C. Sato. 1993. Rapid sequence variation in the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293-1299.
25. Lau, J. Y., M. Mizokami, J. A. Kolberg, G. L. Davis, L. E. Prescott, T. Ohno, R. P. Perrillo, K. L. Lindsay, R. G. Gish, K. P. Qian, et al. 1995. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis. 171:281-290.
26. Lawal, Z., J. Petrik, V. S. Wong, G. J. Alexander, and J. P. Allain. 1997. Hepatitis C virus genome variability in untreated and immunosuppressed patients. Virology 228:107-111.
27. Mao, Q., S. C. Ray, O. Laeyendecker, J. R. Ticehurst, S. A. Strathdee, D. Vlahov, and D. L. Thomas. 2001. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J. Virol. 75:3259-3267.
28. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
29. Martell, M., J. I. Esteban, J. Quer, V. Vargas, R. Esteban, J. Guardia, and J. Gomez. 1994. Dynamic behavior of hepatitis C virus in quasispecies in patients undergoing orthotopic liver transplantation. J. Virol. 68:3425-3436.
30. Martín, M., S. Echecarría, F. Leyva-Cobián, I. Pereda, and M. López-Hoyos. 2001. Limited immune reconstitution at intermediate stages of HIV-1 infection during one year of highly active antiretroviral therapy in antiretroviral-naive versus non-naive adults. Eur. J. Microbiol. Infect. Dis. 20:871-879.
31. Naito, M., N. Hayashi, T. Moribe, H. Hagiwara, E. Mita, Y. Kanazawa, A. Kasahara, H. Fusamoto, and T. Kamada. 1995. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 22:407-412.
32. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
33. Ni, Y.-H., M.-H. Chang, P.-J. Chen, H.-Y. Hsu, T.-W. Lu, K.-H. Lin, and D.-T. Lin. 1999. Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation. J. Med. Virol. 58:132-138.
34. Puoti, M., F. Gargulio, E. Q. Roldan, A. Chiodera, L. Palvarini, A. Spinetti, S. Zaltron, V. Putzolo, B. Zanini, F. Favilli, A. Turano, and G. Carosi. 2000. Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J. Infect. Dis. 181:2033-2036.
35. Ragni, M. V., and F. A. Bontempo. 1999. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J. Infect. Dis. 180:2027-2029.
36. Ray, S. C., Y.-M. Wang, O. Laeyendecker, J. R. Ticehurst, S. A. Villano, and D. L. Thomas. 1999. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region I as a decoy. J. Virol. 73:2938-2946.
37. Rockstroh, J. K., A. Theisen, R. Kaiser, T. Sauerbruch, and U. Spengler. 1998. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV co-infected haemophiliacs. AIDS 12:829-830.
38. Roque-Afonso, A. M., M. Robain, D. Simoneau, P. Rodriguez-Mathieu, M. Gigou, L. Meyer, and E. Dussaix. 2002. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J. Infect. Dis. 185:728-733.
39. Rutschman, O. T., F. Negro, B. Hirsschel, A. Hadengue, D. Anwar, and L. H. Perrin. 1998. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J. Infect. Dis. 177:783-785.
40. Sabin, C. A., P. Telfer, A. N. Phillips, S. Bhagani, and C. A. Lee. 1997. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophiliac men. J. Infect. Dis. 175:164-168.
41. Sánchez-Fueyo, A., M. Giménez-Barcons, F. Puig-Basagoiti, A. Rimola, J. M. Sánchez-Tapias, J. C. Sáiz, and J. Rodés. 2001. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J. Med. Virol. 65:266-275.
42. Seibert, S. A., C. Y. Howell, M. K. Hughes, and A. L. Hughes. 1995. Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol. Biol. Evol. 12:803-813.
43. Sherman, K. E., C. Andreatta, J. O'Brien, A. Gutierrez, and R. Harris. 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23:688-694.
44. Sherman, K. E., J. O'Brien, A. G. Gutierrez, S. Harrison, M. Urdea, P. Neuwald, and J. Wilber. 1993. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J. Clin. Microbiol. 31:2679-2682.
45. Sherman, K. E., S. D. Rouster, R. T. Chung, and N. Rajicic. 2002. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross sectional analysis of the US adult AIDS clinical trials group. Clin. Infect. Dis. 34:831-837.
46. Soriano, V., J. Garcia-Samaniego, R. Bravo, J. Gonzalez, A. Castro, J. Castilla, P. Martinex-Odriozola, M. Colmenero, E. Carballo, D. Suarez, F. J. Rodriguez-Pinero, A. Moreno, J. del Romero, J. Pedreira, J. Gonzalez-Lahoz, et al. 1996. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 23:585-591.
47. Soto, B., A. Sanchez-Quijano, L. Rodrigo, J. A. del Olmo, M. Garcia-Bengoechea, J. Hernandez-Quero, C. Rey, M. A. Abad, M. Rodriguez, M. Sales Gilabert, F. Gonzalez, P. Miron, A. Caruz, F. Relimpio, R. Torronteras, M. Leal, and E. Lissen. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 26:1-5.
48. Tong, M. J., L. M. Blatt, J. G. McHutchison, R. L. Co, and A. Conrad. 1997. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology. 26:1640-1645.
49. Torre, D., R. Tambini, F. Cadario, G. Barbarini, M. Moroni, and C. Basilico. 2001. Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin. Infect. Dis. 33:1579-1585.
50. Toyoda, H., Y. Fukuda, Y. Koyama, J. Takamatsu, H. Saito, and T. Hayakawa. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J. Hepatol. 26:975-982.
51. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
52. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kuntsman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
53. Wright, T. L., H. Hollander, X. Pu, M. J. Held, P. Lipson, S. Quan, A. Polito, M. M. Thaler, P. Bacchetti, and B. F. Scharschimdt. 1994. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 20:1152-1155.
54. Yokozaki, S., J. Takamatsu, I. Nakano, Y. Katano, H. Toyoda, K. Hayashi, T. Hayakawa, and Y. Fukuda. 2001. Highly active antiretroviral therapy and interferon therapy for HIV-HCV-coinfected patients: which should precede? Blood 97:3318-3319.
55. Yokozaki, S., J. Takamatsu, I. Nakano, Y. Katano, H. Toyoda, K. Hayashi, T. Hayakawa, and Y. Fukuda. 2000. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood 96:4293-4299.
56. Zein, N. N., J. Rakela, E. Krawitt, K. R. Reddy, T. Tominaga, and D. Persing. 1996. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann. Intern. Med. 125:634-639.